West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings

robot
Abstract generation in progress

West Pharmaceutical Services Inc. reported strong first-quarter 2026 results with net sales up 21.0% to $844.9 million and diluted earnings per share increasing 56.1% to $1.92. The company saw significant growth in its proprietary products, especially high-value components and delivery devices. West Pharmaceutical also raised its full-year 2026 guidance for net sales and adjusted diluted earnings per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin